MicroRNAs (miRNAs) play a critical role in cancer development and progression. Deregulated expression of miR-204 has been reported in several cancers, but the mechanism through which miR-204 modulates human non-small cell lung cancer (NSCLC) is largely unknown. In this study, we investigate the expression and functional role of miR-204 in human NSCLC tissues and cell lines. RNA isolation, qRT-PCR, MTT, colony formation assay, cell cycle assay, cell apoptosis assay, cell migration assay, and Western blot were performed. Statistical analysis was performed using SPSS 18.0 software and statistical significance was accepted at p value <0.05. miR-204 level was significantly reduced in NSCLC tissues as compared to that of non-neoplastic tissues. Transient over-expression of miR-204 by transfecting with miR-204 mimics suppressed NSCLC cell proliferation, migration, and induced apoptosis and G1 arrest, whereas inhibition of miR-204 showed the converse effects. Additionally, activating transcription factor 2 (ATF2), an important transcription factor, was demonstrated as a potential target gene of miR-204. Subsequent investigations found a negative correlation between miR-204 level and ATF2 expression in NSCLC tissue samples. Moreover, we observed that miR-204 expression inversely affected endogenous ATF2 expression at both mRNA and protein levels in vitro. Taken together, miR-204 may act as a tumor suppressor by directly targeting ATF2 in NSCLC.
NSCLC miR-204 Apoptosis Migration ATF2
This is a preview of subscription content, log in to check access.
This research was supported by a grant from the National Natural Science Foundation of P. R. China (no. 81302029), Natural Science Foundation of Shaanxi Province of P. R. China (no. 2014JQ4149), Fundamental Research Funds for the Central Universities in Xi’an Jiaotong University (no. xjj2015086), and China Postdoctoral Science Foundation (no. 2015M570841).
Li J, Wang Q, Wen R, Liang J, Zhong X, Yang W, et al. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C. J Cell Mol Med. 2015. doi:10.1111/jcmm.12666.Google Scholar
Sun JB, Ji JH, Huo GX, Song QL, Zhang X. miR-182 induces cervical cancer cell apoptosis through inhibiting the expression of DNMT3a. Int J Clin Exp Pathol. 2015;8(5):4755–63.PubMedPubMedCentralGoogle Scholar
Wang XL, Qiu WX, Zhang GQ, Xu SJ, Gao Q, Yang ZL. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway. Int J Clin Exp Pathol. 2015;8(5):5017–25.PubMedPubMedCentralGoogle Scholar
Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, Vieillefond A, et al. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer. Int J Cancer J Int Cancer. 2013;132(11):2479–91. doi:10.1002/ijc.27949.CrossRefGoogle Scholar
Ding M, Lin BY, Li T, Liu YY, Li YH, Zhou XY, et al. A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells. Oncotarget. 2015;6(10):7686–700.CrossRefPubMedPubMedCentralGoogle Scholar
Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V. The role of ATF-2 in oncogenesis. BioEssays : News Rev Mol Cel Dev Biol. 2008;30(4):314–27. doi:10.1002/bies.20734.CrossRefGoogle Scholar
Bhoumik A, Ivanov V, Ronai Z. Activating transcription factor 2-derived peptides alter resistance of human tumor cell lines to ultraviolet irradiation and chemical treatment. Clin Cancer Res Off J Am Assoc Cancer Res. 2001;7(2):331–42.Google Scholar
Li WD, Jin XJ, Zhang QB, Zhang G, Deng XB, Ma L. Decreased expression of miR-204 is associated with poor prognosis in patients with breast cancer. Int J Clin Exp Pathol. 2014;7(6):3287–92.PubMedPubMedCentralGoogle Scholar
Butrym A, Rybka J, Baczynska D, Tukiendorf A, Kuliczkowski K, Mazur G. Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients. J Exp Clin Canc Res. 2015;34:68. doi:10.1186/s13046-015-0184-z.CrossRefGoogle Scholar
Ryan J, Tivnan A, Fay J, Bryan K, Meehan M, Creevey L, et al. MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome (vol 107, pg 967, 2012). Br J Cancer. 2012;107(7):1203. doi:10.1038/bjc.2012.425.CrossRefPubMedCentralGoogle Scholar
Cortinovis D, Monica V, Pietrantonio F, Ceresoli GL, La Spina CM, Wannesson L. MicroRNAs in non-small cell lung cancer: current status and future therapeutic promises. Curr Pharm Des. 2014;20(24):3982–90.CrossRefPubMedGoogle Scholar
Desai S, Kumar A, Laskar S, Pandey BN. Differential roles of ATF-2 in survival and DNA repair contributing to radioresistance induced by autocrine soluble factors in A549 lung cancer cells. Cell Signal. 2014;26(11):2424–35. doi:10.1016/j.cellsig.2014.07.021.CrossRefPubMedGoogle Scholar
Berger AJ, Kluger HM, Li N, Kielhorn E, Halaban R, Ronai Z, et al. Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival. Cancer Res. 2003;63(23):8103–7.PubMedGoogle Scholar
Nagase T, Sudo T, Maekawa T, Yoshimura T, Fujisawa J, Yoshida M, et al. Promoter region of the human Cre-Bp1 gene encoding the transcriptional regulator binding to the cyclic-Amp response element. J Biol Chem. 1990;265(28):17300–6.PubMedGoogle Scholar
Laferriere J, Houle F, Taher MM, Valerie K, Huot J. Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem. 2001;276(36):33762–72. doi:10.1074/jbc.M008564200.CrossRefPubMedGoogle Scholar
Ma Q, Li X, Vale-Cruz D, Brown ML, Beier F, LuValle P. Activating transcription factor 2 controls Bcl-2 promoter activity in growth plate chondrocytes. J Cell Biochem. 2007;101(2):477–87. doi:10.1002/jcb.21198.CrossRefPubMedGoogle Scholar
Decesare D, Vallone D, Caracciolo A, Sassonecorsi P, Nerlov C, Verde P. Heterodimerization of C-Jun with Atf-2 and C-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene. 1995;11(2):365–76.Google Scholar